Gastroenterology and hepatology

Integrative anticoagulation of nafamostat mesylate in double plasma molecular adsorption system plus sequential half-dose plasmapheresis for patients with liver failure: a randomised controlled trial protocol
Xiankun Sun, Fang Wang, Zhiwen Chen, Juan Liao, Yingying Yang, Lang Bai, Ling Zhang

BMJ Open Feb 2025, 15 (2) e098898; DOI: 10.1136/bmjopen-2025-098898
Identifying haemochromatosis patients with C282Y homozygosity from inpatient electronic patient records in England using a novel algorithm: a retrospective observational study
Prabhsimran Singh, Charles Millson, Chao Huang, Robert J Driver

BMJ Open Feb 2025, 15 (2) e089369; DOI: 10.1136/bmjopen-2024-089369
Autoimmune pancreatitis, pancreatic and extrapancreatic cancer (AIPPEAR): a multicentre, retrospective study protocol
Julian Cardinal von Widdern, Cecilie Siggaard Knoph, Karri Kase, Ivonne Regel, Jonas Rosendahl, Christoph Ammer-Hermenau, Sara Nikolic

BMJ Open Feb 2025, 15 (2) e086824; DOI: 10.1136/bmjopen-2024-086824
A qualitative enquiry into participants’ and practitioners’ experiences in the Australian Liver FaIlurE trial
Jeyamani Ramachandran, Anuradha Pati, Luisa Wigg, Sumudu K Narayana, Sharon Lawn, Kate Muller, Alan J Wigg

BMJ Open Feb 2025, 15 (2) e089666; DOI: 10.1136/bmjopen-2024-089666
Association between adjuvant radiotherapy in adults with gastric cancer and risk of second primary malignancy: a retrospective cohort study using the Surveillance, Epidemiology and End Results database
Zheng Li, Zefeng Li, Chongyuan Sun, Xiaojie Zhang, He Fei, Cheng Xing, Dongbing Zhao

BMJ Open Feb 2025, 15 (2) e086349; DOI: 10.1136/bmjopen-2024-086349
Cirrhosis and Faecal microbiota Transplantation (ChiFT) protocol: a Danish multicentre, randomised, placebo-controlled trial in patients with decompensated liver cirrhosis
Sidsel Støy, Lotte Lindgreen Eriksen, Johanne Sloth Lauszus, Søren Damsholt, Simon Mark Dahl Baunwall, Christian Erikstrup, Hendrik Vilstrup, Peter Jepsen, Christian Hvas, Karen Louise Thomsen

BMJ Open Feb 2025, 15 (2) e091078; DOI: 10.1136/bmjopen-2024-091078
What are the lived healthcare experiences of patients with primary sclerosing cholangitis? A community-based qualitative interview study
Katherine Arndtz, Madeline Cameron, Gideon Hirschfield, Jayne Parry, Sheila Greenfield

BMJ Open Feb 2025, 15 (2) e082498; DOI: 10.1136/bmjopen-2023-082498
Rationale and design of a multicentre randomised controlled trial on circulating tumour DNA-guided neoadjuvant treatment strategy for locally advanced rectal cancer (CINTS-R)
Jiaolin Zhou, Xiao Zhang, Qian Liu, Yongheng Li, Guoju Wu, Wei Fu, Hongwei Yao, Zhenjun Wang, Huadan Xue, Tao Xu, Weijie Chen, Junyang Lu, Guannan Zhang, Bin Wu, Yang An, Xiaoyuan Qiu, Yi Xiao, Guole Lin

BMJ Open Jan 2025, 15 (1) e090765; DOI: 10.1136/bmjopen-2024-090765
Chinese herbal formula Tongxie Yaofang granules for diarrhoea-predominant irritable bowel syndrome: a randomised, double-blind, placebo-controlled, phase II trial
Shi-Bing Liang, Hong-Jie Cheng, Qiao-Yan Zhang, Mei Han, Yu-Fei Li, Hui-Juan Cao, Ze-Yu Yu, Ling-Yao Kong, Yan-Mei Cai, Li-Bao An, Bao-Tuan Zhao, Shan-Shan Xu, Ling Yan, Nai-Wei Zhang, Bo-Yi Jia, Wei-Fang Liu, Fang Niu, Ba-Teer Wu, Jin-Ming Song, Shu-Xin Jia, Meng-Meng Shi, Xiao-Na Zhang, Vincent Chi Ho Chung, Nicola Robinson, Jian-Ping Liu

BMJ Open Jan 2025, 15 (1) e088410; DOI: 10.1136/bmjopen-2024-088410
Protocol for a first-in-human feasibility study of T regulatory cells (TR004) for inflammatory bowel disease using (ex vivo) Treg expansion (TRIBUTE)
Beverley Rodger, Jennifer Clough, Joana Vasconcelos, James B Canavan, D Macallan, A Toby Prevost, Graham M Lord, Peter Irving

BMJ Open Jan 2025, 15 (1) e092733; DOI: 10.1136/bmjopen-2024-092733

Main menu

Gastroenterology and hepatology

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Gastroenterology and hepatology

Pages